PT2247285E - Agente terapêutico celular para incontinência de urina compreendendo células estaminais originárias de decídua - Google Patents

Agente terapêutico celular para incontinência de urina compreendendo células estaminais originárias de decídua Download PDF

Info

Publication number
PT2247285E
PT2247285E PT88546361T PT08854636T PT2247285E PT 2247285 E PT2247285 E PT 2247285E PT 88546361 T PT88546361 T PT 88546361T PT 08854636 T PT08854636 T PT 08854636T PT 2247285 E PT2247285 E PT 2247285E
Authority
PT
Portugal
Prior art keywords
decidua
incontinence
urine
stem cells
therapeutic agent
Prior art date
Application number
PT88546361T
Other languages
English (en)
Inventor
Jeong Chan Ra
Hang Young Lee
Jung Youn Jo
Yun Jung Kim
Original Assignee
Rnl Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rnl Bio Co Ltd filed Critical Rnl Bio Co Ltd
Publication of PT2247285E publication Critical patent/PT2247285E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT88546361T 2007-11-30 2008-12-01 Agente terapêutico celular para incontinência de urina compreendendo células estaminais originárias de decídua PT2247285E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20070124010 2007-11-30

Publications (1)

Publication Number Publication Date
PT2247285E true PT2247285E (pt) 2014-07-25

Family

ID=40679167

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88546361T PT2247285E (pt) 2007-11-30 2008-12-01 Agente terapêutico celular para incontinência de urina compreendendo células estaminais originárias de decídua

Country Status (11)

Country Link
US (2) US20110059052A1 (pt)
EP (1) EP2247285B1 (pt)
JP (1) JP5280451B2 (pt)
KR (1) KR101046188B1 (pt)
CN (1) CN101801352B (pt)
CA (1) CA2692765C (pt)
ES (1) ES2478678T3 (pt)
MX (1) MX2010000394A (pt)
PL (1) PL2247285T3 (pt)
PT (1) PT2247285E (pt)
WO (1) WO2009069991A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4953335B2 (ja) * 2009-10-06 2012-06-13 国立大学法人名古屋大学 脂肪組織由来間葉系幹細胞を含有する、***不全又は尿意障害用の細胞製剤
KR20110095218A (ko) * 2010-02-18 2011-08-24 주식회사 강스템홀딩스 ＰＩ３Ｋ／ＡＫＴ／ＧＳＫ３ 경로를 통해 성체줄기세포의 증식, 다분화능 및 재프로그래밍을 촉진하는 ＣＤ４９ｆ
US20140050705A1 (en) 2011-02-25 2014-02-20 Kyungpook National University Hospital Agent for treating urinary incontinence including stem cells derived from amniotic fluid
KR101289834B1 (ko) * 2011-02-25 2013-07-24 경북대학교병원 양수 유래 줄기세포를 함유하는 요실금 치료제
JP6607675B2 (ja) * 2011-07-06 2019-11-20 セル セラピー リミテッド 中胚葉系列の前駆細胞
KR101423659B1 (ko) * 2011-12-27 2014-07-28 경북대학교병원 초기 분화된 양수 줄기세포를 포함하는 요실금 치료제
WO2014040030A1 (en) * 2012-09-10 2014-03-13 Wake Forest University Health Sciences Urine stem cells for skeletal muscle generation and uses thereof
ES2827849B2 (es) * 2019-11-22 2022-07-04 Fundacion Para La Investig Biomedica Del Hospital 12 De Octubre Celulas madre de la decidua parietalis de la placenta para su uso en la incontinencia urinaria de esfuerzo cronica

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5516532A (en) * 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation
US5830708A (en) 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
US5654381A (en) * 1995-06-16 1997-08-05 Massachusetts Institute Of Technology Functionalized polyester graft copolymers
CA2400485C (en) * 2000-02-26 2014-04-29 Artecel Sciences, Inc. Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
EP2336300B1 (en) * 2001-02-14 2015-07-08 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
JP4680483B2 (ja) * 2001-02-23 2011-05-11 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 組織および臓器の治療および修復に用いるための幹細胞マトリックスの迅速な調製方法
US7651684B2 (en) * 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
JP3934539B2 (ja) * 2001-12-12 2007-06-20 独立行政法人科学技術振興機構 胎盤等由来の成体又は生後組織の前駆細胞
WO2003089619A2 (en) * 2002-04-19 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Placental derived stem cells and uses thereof
DK1599575T3 (da) * 2003-02-20 2012-01-16 Cytori Therapeutics Inc Fremgangsmåder til anvendelse af adipøst vævs-afledte celler i behandlingen af kardiovaskulære tilstande
CA2563518C (en) * 2004-04-23 2014-09-02 Bioe, Inc. Multi-lineage progenitor cells
KR100747637B1 (ko) 2004-11-24 2007-08-08 전진현 포유류 배아 및 줄기세포의 미분화 상태 유지 오씨티-4 유전자 발현 억제용 이중나선 알엔에이
KR100745895B1 (ko) 2004-12-14 2007-08-02 한국생명공학연구원 인간 배아줄기세포에 특이적인 단일클론항체
KR100679642B1 (ko) * 2005-11-16 2007-02-06 주식회사 알앤엘바이오 인간 지방조직 유래 다분화능 줄기세포 및 이를 함유하는세포치료제
EP1845154A1 (en) * 2006-04-12 2007-10-17 RNL Bio Co., Ltd. Multipotent stem cells derived from placenta tissue and cellular therapeutic agents comprising the same
KR100871984B1 (ko) 2006-04-12 2008-12-05 주식회사 알앤엘바이오 태반 조직 유래 다능성 줄기세포 및 이를 함유하는세포치료제
CN101473030A (zh) 2006-06-15 2009-07-01 Rnl生物技术株式会社 含有来自人类脂肪组织的多塑性干细胞、成纤维细胞和脂肪或脂肪细胞的整容或整形组合物
KR100773460B1 (ko) 2006-09-22 2007-11-06 노영도 방진 및 방독 마스크
CA2679834A1 (en) * 2007-03-01 2008-09-12 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of endometrial/menstrual cells
KR101425653B1 (ko) 2007-05-02 2014-08-05 라정찬 인간 지방조직 유래 다분화능 줄기세포 및 모낭세포를함유하는 세포치료제
KR20080103637A (ko) 2007-05-25 2008-11-28 주식회사 알앤엘바이오 지방유래 줄기세포를 함유하는 사지말단부 허혈성 질환의세포치료용 조성물
US8455251B2 (en) * 2007-11-09 2013-06-04 Rnl Bio Co., Ltd. Method for isolating and culturing adult stem cells derived from human amniotic epithelium

Also Published As

Publication number Publication date
EP2247285B1 (en) 2014-06-11
ES2478678T3 (es) 2014-07-22
EP2247285A2 (en) 2010-11-10
CA2692765A1 (en) 2009-06-04
CN101801352B (zh) 2013-04-03
JP2010538059A (ja) 2010-12-09
US9211306B2 (en) 2015-12-15
MX2010000394A (es) 2010-05-13
PL2247285T3 (pl) 2014-11-28
CN101801352A (zh) 2010-08-11
JP5280451B2 (ja) 2013-09-04
US20130189232A1 (en) 2013-07-25
KR20090056925A (ko) 2009-06-03
KR101046188B1 (ko) 2011-07-04
US20110059052A1 (en) 2011-03-10
WO2009069991A2 (en) 2009-06-04
CA2692765C (en) 2015-09-22
WO2009069991A3 (en) 2009-08-06
EP2247285A4 (en) 2012-05-02

Similar Documents

Publication Publication Date Title
PT2247285E (pt) Agente terapêutico celular para incontinência de urina compreendendo células estaminais originárias de decídua
IL233377A (en) A matrix containing placental stem cells for the treatment of inflammatory diseases
EP2146632A4 (en) COMPOSITIONS AND METHODS FOR CELLULAR IMAGE PRESENTATION AND THERAPY
GB2446847B (en) Location of Basestation
IL208383A0 (en) Action times for handover of mobile stations
EP2007874A4 (en) PROPAGATION OF PRIMARY CELLS
HK1170258A1 (en) Expansion of nk cells nk
ZA201007762B (en) Applicator for self-expanding intravaginal urinary incontinence devices
IL186749A0 (en) Dihydrothienopyrimidines for the treatment of inflammatory diseases
EP1879578A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
PT2292231E (pt) Agente terapêutico para a estenose do canal espinal
GB0724904D0 (en) Improved soft handover for cellular radio systems
ZA201000278B (en) Human umbilical tissue-derived cell compositions for the treatment of incontinence
EP2434983A4 (en) CORRECTION OF URINARY INCONTINENCE DUE TO VOLTAGE
IL194826A0 (en) Compositions and methods for cellular imaging and therapy
EP1917348A4 (en) ISOLATION OF MULTIPLE LINE STEM CELLS
EP2003978A4 (en) ALLOGENIC CELL THERAPY TO TREAT OPPORTUNISTIC INFECTION
EP2180318A4 (en) DIAGNOSTIC AGENT FOR URINARY CAT PROTEIN
GB0723504D0 (en) Treatment of eukaryotic cellular biomass
EP2418222A4 (en) THERAPEUTIC AGENT FOR DISEASES IN WHICH A NEOPLASTIC PROLIFERATION OF PLASMOCYTES OCCURS
EP2412705A4 (en) NEW THERAPEUTIC AGENT FOR COGNITIVE DEFICIT
ZA200905681B (en) Therapeutic agent for urinary excretion disorder
EP1725247A4 (en) POLYPHENOLS AS AN INTRAVESICAL AGENT FOR THE PREVENTION OF TRANSITIONAL CELLULAR TUMORAL IMPLANTATION
GB2480406B (en) Location of basestation
HU0400289D0 (en) Composition for treatment of urine incontinence